Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions
Clinical and Molecular Hepatology
; : 1-16, 2013.
Article
ي En
| WPRIM
| ID: wpr-88112
المكتبة المسؤولة:
WPRO
ABSTRACT
The application of ultrasound contrast agents (UCAs) is considered essential when evaluating focal liver lesions (FLLs) using ultrasonography (US). Microbubble UCAs are easy to use and robust; their use poses no risk of nephrotoxicity and requires no ionizing radiation. The unique features of contrast enhanced US (CEUS) are not only noninvasiveness but also real-time assessing of liver perfusion throughout the vascular phases. The later feature has led to dramatic improvement in the diagnostic accuracy of US for detection and characterization of FLLs as well as the guidance to therapeutic procedures and evaluation of response to treatment. This article describes the current consensus and guidelines for the use of UCAs for the FLLs that are commonly encountered in US. After a brief description of the bases of different CEUS techniques, contrast-enhancement patterns of different types of benign and malignant FLLs and other clinical applications are described and discussed on the basis of our experience and the literature data.
Key words
النص الكامل:
1
الفهرس:
WPRIM
الموضوع الرئيسي:
Phospholipids
/
Sulfur Hexafluoride
/
Tomography, X-Ray Computed
/
Practice Guidelines as Topic
/
Contrast Media
/
Liver Diseases
/
Liver Neoplasms
نوع الدراسة:
Guideline
المحددات:
Humans
اللغة:
En
مجلة:
Clinical and Molecular Hepatology
السنة:
2013
نوع:
Article